New York State Teachers Retirement System lowered its position in Maximus, Inc. (NYSE:MMS - Free Report) by 12.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,468 shares of the health services provider's stock after selling 10,689 shares during the quarter. New York State Teachers Retirement System owned approximately 0.13% of Maximus worth $4,942,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Hillsdale Investment Management Inc. boosted its stake in Maximus by 0.4% in the fourth quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider's stock worth $3,912,000 after buying an additional 230 shares in the last quarter. UMB Bank n.a. boosted its stake in Maximus by 70.2% in the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after buying an additional 250 shares in the last quarter. Bridge City Capital LLC boosted its stake in Maximus by 0.9% in the fourth quarter. Bridge City Capital LLC now owns 28,503 shares of the health services provider's stock worth $2,128,000 after buying an additional 254 shares in the last quarter. Inspire Advisors LLC boosted its stake in Maximus by 3.1% in the fourth quarter. Inspire Advisors LLC now owns 8,650 shares of the health services provider's stock worth $646,000 after buying an additional 258 shares in the last quarter. Finally, GAMMA Investing LLC boosted its stake in Maximus by 67.1% in the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after buying an additional 294 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.
Maximus Trading Up 1.3%
Shares of Maximus stock traded up $0.91 during midday trading on Thursday, reaching $72.83. 504,759 shares of the company's stock traded hands, compared to its average volume of 572,942. The stock has a 50 day moving average of $71.42 and a 200-day moving average of $70.95. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.84 and a current ratio of 1.84. The company has a market cap of $4.10 billion, a PE ratio of 14.48 and a beta of 0.61. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97.
Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The firm's quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.57 earnings per share. As a group, equities analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Sunday, August 31st. Shareholders of record on Friday, August 15th will be issued a $0.30 dividend. The ex-dividend date is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.65%. Maximus's dividend payout ratio (DPR) is 23.86%.
Insider Activity at Maximus
In other news, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction on Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the sale, the director directly owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. This represents a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.60% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.
Check Out Our Latest Research Report on MMS
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Recommended Stories

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.